“Conscious fabrication” leads to retraction of diabetes study

Diabetologia has retracted a 2011 meeting abstract from a group in Sweden, indicating that the second author has been found guilty of research misconduct — a charge the scientist denies. The abstract, “Reduced syntaxin-5 in skeletal muscle of patients with type 2 diabetes is linked to increased diacylglycerol, activation of PKCtheta and impaired insulin signalling,” … Continue reading “Conscious fabrication” leads to retraction of diabetes study

Second retraction appears for arcade game-like image manipulation

In June, we reported on a retraction in Current Biology that came after a number of PubPeer commenters suggested that the authors had engaged in figure manipulation, memorably comparing watching the published videos to playing the old-school arcade game “Space Invaders.” Now a second paper from the same team has been retracted from Biology Open after the authors “were unable … Continue reading Second retraction appears for arcade game-like image manipulation

“I kind of like that about science:” Harvard diabetes breakthrough muddied by two new papers

Harvard stem cell researcher Doug Melton got a lot of press last year for research on a hormone he named betatrophin, after its supposed ability to increase production of beta cells, which regulate insulin. Now, the conclusions from that paper, which has been cited 59 times, according to Thomson Scientific’s Web of Knowledge, have been called … Continue reading “I kind of like that about science:” Harvard diabetes breakthrough muddied by two new papers

Former NIH lab director faked findings in three papers: ORI

The former director  of the X-ray crystallography lab at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, faked findings in three papers, according to the Office of Research Integrity. Two of the three papers by Bijan Ahvazi were published in 2004, and later retracted in 2007, … Continue reading Former NIH lab director faked findings in three papers: ORI

Neuroscientist who threatened to sue Science-Fraud.org, retracted two papers is out at Tufts

Gizem Donmez, a neuroscientist who has retracted two papers from Cell and the Journal of Biological Chemistry, is no longer in her position at Tufts University, Retraction Watch has learned. A Tufts spokesperson confirmed the news for us yesterday:

U. Illinois chancellor earns mega-correction for duplicate publication

Phyllis Wise, the chancellor of the University of Illinois and an obstetrics researcher, has called for a massive correction of a 2006 paper in Neuroscience for work she appears to have tried to pass off as having been previously unpublished — but which wasn’t. The article, “Estrogen therapy: Does it help or hurt the adult … Continue reading U. Illinois chancellor earns mega-correction for duplicate publication

Molecular Vision retracts three papers from University of Georgia group with error-ridden images

Molecular Vision has issued “full retractions” for a trio of articles by a group of eye researchers. All of the articles were led by Azza El-Remessy, director of the University of Georgia College of Pharmacy’s clinical and therapeutic graduate program. As much as that is, there might be more still with this case. The first … Continue reading Molecular Vision retracts three papers from University of Georgia group with error-ridden images

Weekend reads: A journal that will publish anything, even fake; Wakefield loses defamation suit appeal

This week at Retraction Watch featured revelations about legal threats to PubPeer, and a swift expression of concern for a paper denying the link between HIV and AIDS. Here’s what was happening elsewhere:

Fudged figures sink breast cancer paper

A prestigious cancer journal has pulled an article over “concerns” regarding some of the figures, which PubPeer commenters had tagged as suspect. A few weeks after the paper was published on June 9, comments on PubPeer began accumulating. Commenters called out both potentially manipulated and repeated images. The exact timeline is not clear, because Oncogene does not list … Continue reading Fudged figures sink breast cancer paper